Gynecologic Malignant Tumor Clinical Trial
Official title:
The Study of Massively Parallel Sequencing in Early Detection for Gynecologic Malignant Tumor
As human aging, 50% of women will be faced with the threat of cancer, especially
gynecological malignancies. Ovarian, cervical and endometrial cancer are three major
gynecological malignancies. In recent years, the incidence of cervical cancer, especially in
young women significantly increased; ovarian cancer, although the incidence of malignant
tumors in the female reproductive system ranked second, but its mortality rate already in
the first place; and the morbidity and mortality of endometrial cancer is also rising.
The key to gynecologic malignancies is how to early diagnose and treat. With the advancement
of science and technology, such as molecular biology techniques widely used in the medical
field, early diagnosis, proper treatment and other aspects in gynecologic malignancies is
expected to achieve a breakthrough. Genome-wide scan strategy, making the whole genome for
linkage analysis for gynecological malignancies possible. Therefore, the investigators
intend to find specific mutations to provide a new early screening approach for
gynecological malignancies, which in later result in early diagnosis and specific treatment
for gynecological malignant tumors.
n/a
Observational Model: Case Control, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT04773327 -
Efficacy and Safety of PEG-rhG-CSF in the Prevention of Neutropenia After Chemo in Pts With Gynecological Malignancies
|
N/A |